Activation of Transferrin Receptor 1 by c-Myc Enhances Cellular Proliferation and Tumorigenesis

REFERENCES

• Adhikary, S., and M. Eilers. 2005. Transcriptional regulation and transformation by Myc proteins. Nat. Rev. Mol. Cell. Biol. 6:635–645.
   PubMed Web of Science ®Google Scholar
• Alizadeh, A. A., M. B. Eisen, R. E. Davis, C. Ma, I. S. Lossos, A. Rosenwald, J. C. Boldrick, H. Sabet, T. Tran, X. Yu, J. I. Powell, L. Yang, G. E. Marti, T. Moore, J. Hudson, Jr., L. Lu, D. B. Lewis, R. Tibshirani, G. Sherlock, W. C. Chan, T. C. Greiner, D. D. Weisenburger, J. O. Armitage, R. Warnke, R. Levy, W. Wilson, M. R. Grever, J. C. Byrd, D. Botstein, P. O. Brown, and L. M. Staudt. 2000. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503–511.
   PubMed Web of Science ®Google Scholar
• Becton, D. L., and P. Bryles. 1988. Deferoxamine inhibition of human neuroblastoma viability and proliferation. Cancer Res. 48:7189–7192.
   PubMed Web of Science ®Google Scholar
• Blatt, J., and S. Stitely. 1987. Antineuroblastoma activity of desferoxamine in human cell lines. Cancer Res. 47:1749–1750.
   PubMed Web of Science ®Google Scholar
• Bowen, H., T. E. Biggs, S. T. Baker, E. Phillips, V. H. Perry, D. A. Mann, and C. H. Barton. 2002. c-Myc represses the murine Nramp1 promoter. Biochem. Soc. Trans. 30:774–777.
   PubMedGoogle Scholar
• Bowen, H., A. Lapham, E. Phillips, I. Yeung, M. Alter-Koltunoff, B. Z. Levi, V. H. Perry, D. A. Mann, and C. H. Barton. 2003. Characterization of the murine Nramp1 promoter: requirements for transactivation by Miz-1. J. Biol. Chem. 278:36017–36026.
   PubMedGoogle Scholar
• Boyd, K. E., J. Wells, J. Gutman, S. M. Bartley, and P. J. Farnham. 1998. c-Myc target gene specificity is determined by a post-DNAbinding mechanism. Proc. Natl. Acad. Sci. USA 95:13887–13892.
   PubMed Web of Science ®Google Scholar
• Cheng, Y., O. Zak, P. Aisen, S. C. Harrison, and T. Walz. 2004. Structure of the human transferrin receptor-transferrin complex. Cell 116:565–576.
   PubMed Web of Science ®Google Scholar
• Chitambar, C. R., E. J. Massey, and P. A. Seligman. 1983. Regulation of transferrin receptor expression on human leukemic cells during proliferation and induction of differentiation. Effects of gallium and dimethylsulfoxide. J. Clin. Investig. 72:1314–1325.
   PubMed Web of Science ®Google Scholar
• Cole, M. D., and S. B. McMahon. 1999. The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene 18:2916–2924.
   PubMed Web of Science ®Google Scholar
• Coller, H. A., C. Grandori, P. Tamayo, T. Colbert, E. S. Lander, R. N. Eisenman, and T. R. Golub. 2000. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc. Natl. Acad. Sci. USA 97:3260–3265.
   PubMed Web of Science ®Google Scholar
• Dang, C. V. 1999. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell. Biol. 19:1–11.
   PubMed Web of Science ®Google Scholar
• Eilers, M., D. Picard, K. R. Yamamoto, and J. M. Bishop. 1989. Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature 340:66–68.
   PubMedGoogle Scholar
• Elbashir, S. M., J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494–498.
   PubMed Web of Science ®Google Scholar
• Ellwood-Yen, K., T. G. Graeber, J. Wongvipat, M. L. Iruela-Arispe, J. Zhang, R. Matusik, G. V. Thomas, and C. L. Sawyers. 2003. Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 4:223–238.
   PubMed Web of Science ®Google Scholar
• Fan, L., J. Iyer, S. Zhu, K. K. Frick, R. K. Wada, A. E. Eskenazi, P. E. Berg, N. Ikegaki, R. H. Kennett, and C. N. Frantz. 2001. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells. Cancer Res. 61:1073–1079.
   PubMed Web of Science ®Google Scholar
• Feremans, W., W. Bujan, P. Neve, J. P. Delville, and L. Schandene. 1991. CD71 phenotype and the value of gallium imaging in lymphomas. Am. J. Hematol. 36:215–216.
   PubMed Web of Science ®Google Scholar
• Fernandez, P. C., S. R. Frank, L. Wang, M. Schroeder, S. Liu, J. Greene, A. Cocito, and B. Amati. 2003. Genomic targets of the human c-Myc protein. Genes Dev. 17:1115–1129.
   PubMed Web of Science ®Google Scholar
• Gatter, K. C., G. Brown, I. S. Trowbridge, R. E. Woolston, and D. Y. Mason. 1983. Transferrin receptors in human tissues: their distribution and possible clinical relevance. J. Clin. Pathol. 36:539–545.
   PubMed Web of Science ®Google Scholar
• Grandori, C., and R. N. Eisenman. 1997. Myc target genes. Trends Biochem. Sci. 22:177–181.
   PubMedGoogle Scholar
• Grandori, C., J. Mac, F. Siebelt, D. E. Ayer, and R. N. Eisenman. 1996. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo. EMBO J. 15:4344–4357.
   PubMedGoogle Scholar
• Haggerty, T. J., K. I. Zeller, R. C. Osthus, D. R. Wonsey, and C. V. Dang. 2003. A strategy for identifying transcription factor binding sites reveals two classes of genomic c-Myc target sites. Proc. Natl. Acad. Sci. USA 100:5313–5318.
   PubMedGoogle Scholar
• Hanson, K. D., M. Shichiri, M. R. Follansbee, and J. M. Sedivy. 1994. Effects of c-myc expression on cell cycle progression. Mol. Cell. Biol. 14:5748–5755.
   PubMedGoogle Scholar
• Hosack, D. A., G. Dennis, Jr., B. T. Sherman, H. C. Lane, and R. A. Lempicki. 2003. Identifying biological themes within lists of genes with EASE. Genome Biol. 4:R70.
   PubMed Web of Science ®Google Scholar
• Iritani, B. M., and R. N. Eisenman. 1999. c-Myc enhances protein synthesis and cell size during B lymphocyte development. Proc. Natl. Acad. Sci. USA 96:13180–13185.
   PubMed Web of Science ®Google Scholar
• Kemp, J. D., K. M. Smith, J. M. Mayer, F. Gomez, J. A. Thorson, and P. W. Naumann. 1992. Effects of anti-transferrin receptor antibodies on the growth of neoplastic cells. Pathobiology 60:27–32.
   PubMed Web of Science ®Google Scholar
• Kuhn, L. C. 1989. The transferrin receptor: a key function in iron metabolism. Schweiz. Med. Wochenschr. 119:1319–1326.
   PubMedGoogle Scholar
• Larrick, J. W., and P. Cresswell. 1979. Modulation of cell surface iron transferrin receptors by cellular density and state of activation. J. Supramol. Struct. 11:579–586.
   PubMedGoogle Scholar
• Li, F., Y. Wang, K. I. Zeller, J. J. Potter, D. R. Wonsey, K. A. O'Donnell, J. W. Kim, J. T. Yustein, L. A. Lee, and C. V. Dang. 2005. Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol. Cell. Biol. 25:6225–6234.
   PubMed Web of Science ®Google Scholar
• Li, Z., S. Van Calcar, C. Qu, W. K. Cavenee, M. Q. Zhang, and B. Ren. 2003. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc. Natl. Acad. Sci. USA 100:8164–8169.
   PubMed Web of Science ®Google Scholar
• Linke, S. P., K. C. Clarkin, A. Di Leonardo, A. Tsou, and G. M. Wahl. 1996. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev. 10:934–947.
   PubMed Web of Science ®Google Scholar
• Lossos, I. S., A. A. Alizadeh, M. Diehn, R. Warnke, Y. Thorstenson, P. J. Oefner, P. O. Brown, D. Botstein, and R. Levy. 2002. Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proc. Natl. Acad. Sci. USA 99:8886–8891.
   PubMed Web of Science ®Google Scholar
• Mateyak, M. K., A. J. Obaya, S. Adachi, and J. M. Sedivy. 1997. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ. 8:1039–1048.
   PubMedGoogle Scholar
• Moura, I. C., Y. Lepelletier, B. Arnulf, P. England, C. Baude, C. Beaumont, A. Bazarbachi, M. Benhamou, R. C. Monteiro, and O. Hermine. 2003. A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients. Blood 103:1838–1845.
   PubMedGoogle Scholar
• Neckers, L. M., and J. B. Trepel. 1986. Transferrin receptor expression and the control of cell growth. Cancer Investig. 4:461–470.
   PubMed Web of Science ®Google Scholar
• Nikiforov, M. A., S. Chandriani, B. O'Connell, O. Petrenko, I. Kotenko, A. Beavis, J. M. Sedivy, and M. D. Cole. 2002. A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism. Mol. Cell. Biol. 22:5793–5800.
   PubMed Web of Science ®Google Scholar
• O'Connell, B. C., A. F. Cheung, C. P. Simkevich, W. Tam, X. Ren, M. K. Mateyak, and J. M. Sedivy. 2003. A large scale genetic analysis of c-Myc-regulated gene expression patterns. J. Biol. Chem. 278:12563–12573.
   PubMed Web of Science ®Google Scholar
• O'Donnell, K. A., E. A. Wentzel, K. I. Zeller, C. V. Dang, and J. T. Mendell. 2005. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435:839–843.
   PubMed Web of Science ®Google Scholar
• Orian, A., B. van Steensel, J. Delrow, H. J. Bussemaker, L. Li, T. Sawado, E. Williams, L. W. Loo, S. M. Cowley, C. Yost, S. Pierce, B. A. Edgar, S. M. Parkhurst, and R. N. Eisenman. 2003. Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network. Genes Dev. 17:1101–1114.
   PubMed Web of Science ®Google Scholar
• Oster, S. K., C. S. Ho, E. L. Soucie, and L. Z. Penn. 2002. The myc oncogene: MarvelouslY Complex. Adv. Cancer Res. 84:81–154.
   PubMed Web of Science ®Google Scholar
• Oster, S. K., D. Y. Mao, J. Kennedy, and L. Z. Penn. 2003. Functional analysis of the N-terminal domain of the Myc oncoprotein. Oncogene 22:1998–2010.
   PubMedGoogle Scholar
• Pajic, A., D. Spitkovsky, B. Christoph, B. Kempkes, M. Schuhmacher, M. S. Staege, M. Brielmeier, J. Ellwart, F. Kohlhuber, G. W. Bornkamm, A. Polack, and D. Eick. 2000. Cell cycle activation by c-myc in a burkitt lymphoma model cell line. Int. J. Cancer 87:787–793.
   PubMed Web of Science ®Google Scholar
• Pelengaris, S., M. Khan, and G. Evan. 2002. c-MYC: more than just a matter of life and death. Nat Rev. Cancer 2:764–776.
   PubMed Web of Science ®Google Scholar
• Remondini, D., B. O’Connell, B. Intrator, J. M. Sedivy, N. Neretti, G. C. Castellani, and L. N. Cooper. 2005. Targeting c-Myc activated genes with a correlation method: detection of global changes in large gene expression network dynamics. Proc. Natl. Acad. Sci. USA 102:6902–6906.
   PubMedGoogle Scholar
• Rhodes, D. R., J. Yu, K. Shanker, N. Deshpande, R. Varambally, D. Ghosh, T. Barrette, A. Pandey, and A. M. Chinnaiyan. 2004. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6:1–6.
   PubMed Web of Science ®Google Scholar
• Richardson, D. R. 2002. Iron chelators as therapeutic agents for the treatment of cancer. Crit. Rev. Oncol. Hematol. 42:267–281.
   PubMed Web of Science ®Google Scholar
• Richardson, D. R. 2002. Therapeutic potential of iron chelators in cancer therapy. Adv. Exp. Med. Biol. 509:231–249.
   PubMed Web of Science ®Google Scholar
• Schuhmacher, M., F. Kohlhuber, M. Holzel, C. Kaiser, H. Burtscher, M. Jarsch, G. W. Bornkamm, G. Laux, A. Polack, U. H. Weidle, and D. Eick. 2001. The transcriptional program of a human B cell line in response to Myc. Nucleic Acids Res. 29:397–406.
   PubMed Web of Science ®Google Scholar
• Secombe, J., S. B. Pierce, and R. N. Eisenman. 2004. Myc: a weapon of mass destruction. Cell 117:153–156.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and R. A. DePinho. 2000. Cellular senescence: mitotic clock or culture shock? Cell 102:407–410.
   PubMed Web of Science ®Google Scholar
• Small, M. B., N. Hay, M. Schwab, and J. M. Bishop. 1987. Neoplastic transformation by the human gene N-myc. Mol. Cell. Biol. 7:1638–1645.
   PubMed Web of Science ®Google Scholar
• Stone, J., T. de Lange, G. Ramsay, E. Jakobovits, J. M. Bishop, H. Varmus, and W. Lee. 1987. Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol. Cell. Biol. 7:1697–1709.
   PubMed Web of Science ®Google Scholar
• Su, A. I., M. P. Cooke, K. A. Ching, Y. Hakak, J. R. Walker, T. Wiltshire, A. P. Orth, R. G. Vega, L. M. Sapinoso, A. Moqrich, A. Patapoutian, G. M. Hampton, P. G. Schultz, and J. B. Hogenesch. 2002. Large-scale analysis of the human and mouse transcriptomes. Proc. Natl. Acad. Sci. USA 99:4465–4470.
   PubMed Web of Science ®Google Scholar
• Taetle, R., J. M. Honeysett, and I. Trowbridge. 1983. Effects of anti-transferrin receptor antibodies on growth of normal and malignant myeloid cells. Int. J. Cancer 32:343–349.
   PubMed Web of Science ®Google Scholar
• Vindelov, L. L., I. J. Christensen, and N. I. Nissen. 1983. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3:323–327.
   PubMedGoogle Scholar
• Weiner, R. E. 1996. The mechanism of 67Ga localization in malignant disease. Nucl. Med. Biol. 23:745–751.
   PubMedGoogle Scholar
• Wonsey, D. R., K. I. Zeller, and C. V. Dang. 2002. The c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation. Proc. Natl. Acad. Sci. USA 99:6649–6654.
   PubMed Web of Science ®Google Scholar
• Woo, R. A., and R. Y. Poon. 2004. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation. Genes Dev. 18:1317–1330.
   PubMed Web of Science ®Google Scholar
• Wu, K. J., A. Polack, and R. Dalla-Favera. 1999. Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC. Science 283:676–679.
   PubMed Web of Science ®Google Scholar
• Yu, D., D. Allman, M. H. Goldschmidt, M. L. Atchison, J. G. Monroe, and A. Thomas-Tikhonenko. 2003. Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway. Blood 101:1950–1955.
   PubMedGoogle Scholar
• Yu, D., M. Dews, A. Park, J. W. Tobias, and A. Thomas-Tikhonenko. 2005. Inactivation of Myc in murine two-hit B lymphomas causes dormancy with elevated levels of interleukin 10 receptor and CD20: implications for adjuvant therapies. Cancer Res. 65:5454–5461.
   PubMedGoogle Scholar
• Yu, D., and A. Thomas-Tikhonenko. 2002. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis. Oncogene 21:1922–1927.
   PubMedGoogle Scholar
• Zeller, K. I., T. J. Haggerty, J. F. Barrett, Q. Guo, D. R. Wonsey, and C. V. Dang. 2001. Characterization of nucleophosmin (B23) as a Myc target by scanning chromatin immunoprecipitation. J. Biol. Chem. 276:48285–48291.
   PubMed Web of Science ®Google Scholar
• Zeller, K. I., A. G. Jegga, B. J. Aronow, K. A. O'Donnell, and C. V. Dang. 2003. An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets. Genome Biol. 4:R69.
   PubMed Web of Science ®Google Scholar